Advances in Hemophilia Treatment

E. Carlos Rodríguez-Merchán is a Specialist in Orthopedic Surgery and “Emeritus” Consultant Orthopedic Surgeon currently working at the Department of Orthopedic Surgery, La Paz University Hospital, Madrid, Spain. Dr. Rodríguez-Merchán graduated from Complutense University with a degree in Medicine and Surgery in 1974, and subsequently completed a PhD in Medicine and Surgery. He is a former Associate Professor of Orthopedics at the Autonomous University of Madrid. Dr. Rodríguez-Merchán is the author of more than 300 articles in peer-reviewed PubMed-cited journals, as well as 11 books.

• 1. Pathophysiology of hemophilia.- 2. Genetics of Hemophilia A and B.- 3. Inhibitors in Hemophilia A.- 4. Immune Tolerance In Patients with Hemophilia A.- 5. Hemophilia A: New drugs.- 6. Inhibitors in Hemophilia B.- 7. Immune Tolerance Induction in Hemophilia B.- 8. Hemophilia B: New Drugs.- 9. Management of Hemophilia Carriers.- 10. Pharmacoeconomic Aspects in Hemophilia.- 11. Assessment of Joint Health and Outcome Measures in Hemophilia.- 12. Musculoskeletal Medicine in Hemophilia.- 13. Management of Acute Hemarthrosis in Hemophilia (Including Joint Aspiration).- 14. Hemophilic Arthropathy: Radiosynovectomy.- 15. Hemophilic Arthropathy: Arthroscopic Joint Debridement.- 16. Hemophilic Arthropathy: Total Joint Arthroplasty.- 17. Hemophilic Arthropathy: Other Orthopedic Procedures.- 18. Gene Therapy in Hemophilia: Latest Advances.- 19.A Summary of the Recent Recommendations of the WFH.